Cystic brain metastases in ALK-rearranged non-small cell lung cancer.

about

Cystic brain metastases in ALK-rearranged non-small cell lung cancer.

Item

http://www.wikidata.org/entity/Q54980901

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Cystic brain metastases in ALK-rearranged non-small cell lung cancer.

@en

Cystic brain metastases in ALK-rearranged non-small cell lung cancer.

@nl

type

Item

label

Cystic brain metastases in ALK-rearranged non-small cell lung cancer.

@en

Cystic brain metastases in ALK-rearranged non-small cell lung cancer.

@nl

prefLabel

Cystic brain metastases in ALK-rearranged non-small cell lung cancer.

@en

Cystic brain metastases in ALK-rearranged non-small cell lung cancer.

@nl

P1476

Cystic brain metastases in ALK-rearranged non-small cell lung cancer.

@en

P2093

Gilberto de Castro

http://www.w3.org/2001/XMLSchema#string

Guilherme Nader Marta

http://www.w3.org/2001/XMLSchema#string

Henrique Bortot Zuppani

http://www.w3.org/2001/XMLSchema#string

Renata Eiras Martins

http://www.w3.org/2001/XMLSchema#string

Renata Rodrigues da Cunha Colombo Bonadio

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial.

Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial.

Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014.

Characteristics and treatments of large cystic brain metastasis: radiosurgery and stereotactic aspiration

P304

818

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3332/ECANCER.2018.818

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29662531

http://www.w3.org/2001/XMLSchema#string

P932

5880229

http://www.w3.org/2001/XMLSchema#string